A veteran physician researcher shares tips on getting started in clinical trials, obtaining funding, following regulatory standards and making your research efforts a success.
A genotype found to be associated with reduced cardiovascular events in a study of dalcetrapib wasn’t associated with benefit in a trial of fellow CETP inhibitor evacetrapib.
This substudy of the huge PRECISION trial shows that clinicians need to weigh the potential dangers of worsened blood pressure control when considering chronic use of NSAIDs — especially ibuprofen.
The ACCELERATE trial found no effect on cardiac events with evacetrapib despite large HDL gains and solid LDL declines. A substudy presented at ESC 2017 now shows the drug fared no better when analysis was limited to diabetic patients.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
The transcatheter approach to aortic valve replacement in intermediate-risk patients appears to curb the risk of these potentially deadly effects, new subanalyses presented at ACC.17 show.
Make room in your schedule at the American College of Cardiology meeting for key presentations ranging from the SPIRE 1 and 2 trials to ABSORB III two-year results and more.
Long-standing hope for MDCO-216, which contains the ApoA-1 Milano variant of HDL, disappears as the compound fails to yield coronary plaque regression. But the jury’s still out on other HDL-targeted therapies.
Ketamine has emerged as an alternative to electroconvulsive therapy for treatment-resistant depression, but no study has compared the two. A major research project led by Cleveland Clinic is changing that.
A consortium of heart researchers is taking issue with some high-profile proposals for expanded sharing of clinical trial data. A top researcher explains their concerns and outlines an alternate proposal.
Here’s why Cleveland Clinic founded its homegrown academic research organization 25 years ago — and how it continues to shape medical progress and maintain trust in the clinical trials process.